Established in 2005, Modavar Pharmaceuticals is a Washington, D.C.-headquartered subsidiary of India’s Cadila Pharmaceuticals and a specialty pharmaceutical company. Its FDA-approved Frederick, Maryland facility gives the company a U.S. base for developing and manufacturing topical products, while its broader work supports pharmaceutical partners serving the U.S. and European markets.
U.S. FDA Approved
Compliance program
cGMP-Compliant Manufacturing Services
Compliance program
WHO Geneva Approval
Compliance program
UK MHRA Approval
Compliance program
TGA Australia Approval
Compliance program
MCC South Africa Approval
Compliance program
ANVISA Brazil Approval
Compliance program
OSHA Policies
Compliance program
FDA
Quality certification
WHOGMP
Quality certification